Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pramipexole hydrochloride sustained-release pharmaceutical composition and preparation method thereof

A technology of pramipexole hydrochloride and composition, which is applied in the field of pramipexole hydrochloride sustained-release pharmaceutical composition and its preparation, and can solve the problems of slow and stable release of pramipexole hydrochloride and the like

Active Publication Date: 2022-04-08
海思科制药(眉山)有限公司
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Aiming at the deficiencies in the above-mentioned prior art, the present invention adopts the sustained-release preparation technology to solve the problem of slow and steady release of pramipexole hydrochloride while improving the solubility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pramipexole hydrochloride sustained-release pharmaceutical composition and preparation method thereof
  • A kind of pramipexole hydrochloride sustained-release pharmaceutical composition and preparation method thereof
  • A kind of pramipexole hydrochloride sustained-release pharmaceutical composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The following specific embodiments are a further description of the present invention, and should not be considered as a limitation of the protection scope of the present invention. This is the prescription and process for 10,000 tablets, and the units are in grams.

[0025]

[0026]

[0027] 1. Weigh each raw and auxiliary material according to the theoretical amount for subsequent use;

[0028] 2. Pass through a 80-mesh sieve for pramipexole hydrochloride, take hypromellose, starch, carbomer, and colloidal silicon dioxide and pass through a 60-mesh sieve respectively and mix them. Put the mixed materials in a V-type mixer at 24-36 rpm Minutes, mixed for 30-35min;

[0029]3. Add magnesium stearate to the second step, 24-36 rpm, mix for 10-15min;

[0030] 4. Take the mixed material and press it into tablets.

[0031]

[0032]

[0033] Result evaluation:

[0034] (1) release in pH6.8 medium: after embodiment 1 prescription adjusts hypromellose K4M consumpt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pramipexole hydrochloride slow-release composition and a preparation method thereof. The slow-release granules are made of the following raw materials in parts by weight: pramipexole hydrochloride, a lubricant, a skeleton slow-release material, and a filler. Pramipexole hydrochloride is a new anti-Parkinson drug with unique dopamine agonist characteristics and neuroprotective effect. This medicine is an aminobenzothiazole compound, non-ergot selective dopamine D 2 Receptor family agonists are used to treat early and advanced PD, either alone or in combination with levodopa. The invention solves the problem of slowly and stably releasing the pramipexole hydrochloride while improving the solubility of the pramipexole hydrochloride.

Description

technical field [0001] The invention relates to a sustained-release pharmaceutical composition, in particular to a sustained-release pramipexole hydrochloride pharmaceutical composition and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Pramipexole Dihydrochloride Monohydrate, Chinese and English chemical name (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamino Dihydrochloride monohydrate, (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamino)dihydrochloridemonohydrate; Chemical Abstracts Number CAS: 191217-81 -9. [0003] Pramipexole Hydrochloride (Pramipexole Dihydrochloride) is a non-ergotamine dopamine D2 receptor agonist, developed by Boehringer Ingelheim, Germany, and first listed in the United States on May 10, 1997, with the trade name Mirapex. [0004] Drug therapy remains the mainstay of Parkinson's disease relief. The results of a large number of clinical trials have proved the s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/22A61K31/428A61K47/38A61K47/26A61K47/36A61K47/32A61P25/16
CPCA61K9/0002A61K9/2018A61K9/2027A61K9/2054A61K9/2059A61K31/428
Inventor 熊小君姚志昂施薛娇李丹陈九龙
Owner 海思科制药(眉山)有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com